ArticleCancer chemotherapy and pharmacology2025

Prediction of CYP3A4-mediated drug-drug interactions of a novel Bcl-2 inhibitor TQB3909 using physiologically based pharmacokinetic modeling.

Hui Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.